Skip to main content

Personalized Medicine (PM) Market Set Close To USD 2452.50 billion From 2024

 personalized medicine market is expected to cross USD 2452.50 billion by 2022 with a rise in CAGR of 11.8%. Personalized medicine is a branch of medical science encompassing the unique attributes of patients, particularly the genetic design, previous treatment history, behavioural attributes and environmental factors. It enables therapeutic and preventions for emphasizing the most beneficial treatment with low side effects.

To cope up with biopharmaceutical research & development, companies such as Pfizer have introduced “precision medicine”, which is capable of delivering treatments based on disease mechanism and the capacity to target and develop therapies for patients.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/personalized-medicine-market/request-sample

Personalized medicine market is driven by rise in reimbursement support & regulatory framework coupled with increase in R&D activities for next generation sequencing for genetic mapping of patients by clinicians and medical practitioners. Rise in healthcare expenditures stimulates the need for effective diagnostics for cancer and increase in prevalence of chronic ailments coupled with use of biomarkers for therapeutics is expected to bolster the market growth during the forecast period. Product segmentation for personalized medicine (PM) market includes PM diagnostics, PM therapeutics, personalized nutrition & wellness and personalized medical care.

Geographical segmentation for personalized medicine industry comprises North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the global market due to rise in government funding, healthcare enhancements and technological innovations. In addition, awareness about genetic diagnostics, genome sequencing and therapeutics is likely to contribute to the market growth in the forecast period.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/personalized-medicine-market

 

Asia-Pacific regions are likely to grow in the estimated period due to rise in technical advances, unmet medical needs and a mass awareness throughout the industry for infectious disease, psychiatry and CNS disorders. The key players in the personalized medicine market include Quest Diagnostics, 3G Biotech, Laboratory Corporation of America, Abbott, Asuragen Inc, Becton Dickinson & Co, CardioDX Inc.

Market Segment:

Global Personalized Medicine Product Outlook (Revenue, USD Billion, 2012 - 2022)
    • PM Diagnostics
        • Genetic Testing
        • Direct-to-consumer Diagnostics
        • Esoteric Lab Services
        • Esoteric Lab Tests
    • PM Therapeutics
        • Pharmaceutical
        • Genomic Medicine
        • Medical Devices
    • Personalized Medical Care
        • Telemedicine
        • Healthcare Information Technology
        • Diseases Management
    • Personalized Nutrition & Wellness
        • Retail Nutrition
        • Complementary Medicine
        • Alternative Medicine

Labels:

Comments

Post a Comment

Download Free Popular Research

Global Food Grade & Pharma Grade Calcium Phosphate Market Will Generate Maximum Revenue From 2020 To 2025

  Nov 05 2020:   The global   Food Grade & Pharma Grade Calcium Phosphate market   was valued at $XX million in 2018, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Food Grade & Pharma Grade Calcium Phosphate from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Food Grade & Pharma Grade Calcium Phosphate market. To Request A Sample Copy Of This Report @:     https://www.radiantinsights.com/research/2013-2028-report-on-global-food-grade-and-pharma-grade-calcium-phosphate-market/request-sample Leading players of Food Grade & Pharma Grade Calcium Phosphate including: Innophos Prayon ICL PP Chengxing Industrial Hens Budenheim Tianjia Chem Hindus
2 comments
Read more

Global IT Equipment Disposal Market Analysis, Size, Share, Growth, Trends and Forecast 2018-2028: Radiant Insights Inc

April 12, 2019:  The global IT Equipment Disposal market was valued at $XX million in 2017, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market/request-sample This report provides detailed historical analysis of global market for IT Equipment Disposal from 2013-2018 and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the IT Equipment Disposal market. To Browse Full Research Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market Leading players of IT Equipment Disposal including: Eletronic Recyclers International Sims Recycling Solutions Waste Manag
Post a Comment
Read more

Cervical Cancer Diagnostic Market Worth About USD 12 billion By 2024

  Cervical Cancer Diagnostic Market size is anticipated to reach USD 12 billion by 2024. Cervical cancer is caused due to uncontrolled cell division of cancerous or abnormal cell growth in the cervix region. The factors that propel the growth of the cervical cancer diagnostics market include increase in aging female population, rise in the awareness programs for cervical cancer screening, high occurrence rate, and rapid adoption of technology. Moreover, increasing consciousness among the population regarding prevention, care, and treatment of cervical cancer, and availability of advanced and variety of treatment are likely to offer impetus to the market. On the other hand, there are factors that may hamper the growth of the market including lack of awareness related to cervical cancer protection, and changes in regulatory guidelines for cervical cancer screening. Cervical cancer diagnostics industry is anticipated to grow at a significant CAGR of 5.9% in the upcoming period as the sc
Post a Comment
Read more